Unibios Holdings S.A (BIOSK) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.027x

Based on the latest financial reports, Unibios Holdings S.A (BIOSK) has a cash flow conversion efficiency ratio of 0.027x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€372.03K ≈ $434.95K USD) by net assets (€13.80 Million ≈ $16.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Unibios Holdings S.A balance sheet quality to measure how much of total assets are equity-financed.

Unibios Holdings S.A - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Unibios Holdings S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BIOSK cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Unibios Holdings S.A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Unibios Holdings S.A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Exel Composites Oyj HE:EXL1V	0.102x
HCL Infosystems Limited NSE:HCL-INSYS	0.049x
EM-Tech.CO. LTD KQ:091120	0.018x
SMS Lifesciences India Limited NSE:SMSLIFE	0.153x
Hanil Forging Industrial Co. Ltd KQ:024740	0.039x
Wisher Industrial Co Ltd TW:1465	-0.178x
Quorum Information Technologies Inc V:QIS	0.059x
International Distributions Services PLC LSE:IDS	0.045x

Annual Cash Flow Conversion Efficiency for Unibios Holdings S.A (2014–2025)

The table below shows the annual cash flow conversion efficiency of Unibios Holdings S.A from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Unibios Holdings S.A stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€21.27 Million ≈ $24.87 Million	€546.05K ≈ $638.39K	0.026x	+199.95%
2024-12-31	€17.46 Million ≈ $20.41 Million	€149.43K ≈ $174.71K	0.009x	-84.58%
2023-12-31	€15.66 Million ≈ $18.31 Million	€869.22K ≈ $1.02 Million	0.056x	+137.76%
2022-12-31	€13.50 Million ≈ $15.78 Million	€-1.98 Million ≈ $-2.32 Million	-0.147x	-277.98%
2021-12-31	€12.83 Million ≈ $15.00 Million	€1.06 Million ≈ $1.24 Million	0.083x	+1221.31%
2020-12-31	€11.75 Million ≈ $13.74 Million	€-86.55K ≈ $-101.19K	-0.007x	+90.65%
2019-12-31	€11.82 Million ≈ $13.82 Million	€-931.36K ≈ $-1.09 Million	-0.079x	+30.50%
2018-12-31	€8.28 Million ≈ $9.68 Million	€-938.68K ≈ $-1.10 Million	-0.113x	-2002.32%
2017-12-31	€8.66 Million ≈ $10.12 Million	€51.58K ≈ $60.30K	0.006x	+115.64%
2016-12-31	€9.04 Million ≈ $10.57 Million	€-344.32K ≈ $-402.54K	-0.038x	-244.52%
2015-12-31	€11.08 Million ≈ $12.95 Million	€292.00K ≈ $341.38K	0.026x	+15.57%
2014-12-31	€11.58 Million ≈ $13.54 Million	€264.00K ≈ $308.64K	0.023x	--

About Unibios Holdings S.A

AT:BIOSK Greece Pollution & Treatment Controls

Market Cap

$53.72 Million

€45.95 Million EUR

Market Cap Rank

#22525 Global

#77 in Greece

Share Price

€2.64

Change (1 day)

+0.57%

52-Week Range

€2.18 - €3.18

All Time High

€3.18